Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Eliminate high-cost beta-ionone and hazardous ozonization in beta-cyclocitral production. Our new method offers 95% yield, 99% purity, and green manufacturing for fragrance synthesis.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Solve heavy metal contamination in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process cuts costs & ensures GMP compliance for drug development.
Eliminate CO gas handling risks and reduce production costs with this scalable multi-component synthesis for high-purity pharmaceutical intermediates.
Solve capecitabine production challenges with non-toxic alkoxycarbonylation. Avoid phosgene, reduce EHS risks, and achieve >80% yields for stable supply chains.
Discover cost-effective, high-yield synthesis of tetrahydro-beta-carboline ketone using cobalt catalysis. Reduce supply chain risks with scalable, functional group-tolerant process.
Reduce production costs by 30% with this catalyst achieving >95% ee in asymmetric reactions. Ideal for pharma R&D and procurement teams.
Discover how cobalt-catalyzed C-H activation enables cost-effective, scalable tetrahydro-beta-carbolinone production for drug development. Reduce supply chain risks with high-purity intermediates.
Solve low yield & high cost in beta-nitroalcohol production. Our chiral copper catalysis achieves >95% yield, 96% ee, and green ethanol solvent. Scale to 100MT/yr.
Solve high-cost pyrone synthesis with new method using cheap nitroarenes. 99% purity, 24h reaction, no special equipment. Scale to 100MT/yr.
Discover how palladium-catalyzed carbonylation enables one-step benzofuran-3-carboxamide synthesis with high substrate tolerance, reducing production costs and supply chain risks for pharmaceutical intermediates.
Eliminate CO gas handling risks & reduce costs by 30% with this scalable multi-component synthesis for high-purity pharmaceutical intermediates. Contact us for custom production.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Solve wastewater challenges in ribavirin intermediate manufacturing. New 3-step synthesis cuts waste by 70% with 84% yield. Ensure supply chain stability for API production.
Discover efficient one-step synthesis of benzofuran-3-carboxamide with high functional group tolerance. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover how N-heterocyclic carbine catalysis enables high-yield, enantioselective synthesis of spiro hydroxyindole pentamethylene beta-lactones for drug development and insecticide production.
Solve CO gas safety risks and low substrate tolerance in biheterocycle synthesis. Our CDMO expertise scales this metal-catalyzed method to 100MT/yr with >99% purity.
Solve tetracaine production challenges: 70%+ total yield, 99.9% purity, and reduced energy costs. NINGBO INNO PHARMCHEM scales this patent-validated process for your API needs.
Eliminate CO gas risks and high costs in biheterocyclic synthesis. Our CDMO expertise scales this patent method to 100MT/yr with >99% purity for drug development.
Solve meloxicam production challenges with DMSO-based synthesis: 92% yield, 99.5% purity, and reduced toxic solvent use. Scale efficiently with CDMO expertise.